Search

everythinglearnresearchcommunity

for

Search:↓

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

Some skin diseases and their treatments can negatively affect male fertility.

Certain genetic variants in the androgen receptor are linked to higher PSA levels, potentially affecting prostate cancer screening outcomes.

Finasteride for hair loss is safe and does not increase the risk of high-grade prostate cancer.

PSA levels could help detect illegal steroid use in female athletes but face challenges like cost and PCOS prevalence.

Baldness in men with prostate cancer is linked to higher levels of certain sex hormones, but chest hair density is not.

PSA levels are higher in women with PCOS, but FAI is a more accurate marker for diagnosis.

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.

Male pattern baldness might have evolved to help protect against prostate cancer by increasing UV radiation on the scalp.

Genetic differences within ethnic groups may affect prostate cancer treatment effectiveness.

The index to ring finger ratio may indicate disease severity in female ankylosing spondylitis patients, but not in males.

Baldness, especially at the front, may lower the risk of testicular cancer by 31%, but its link to prostate cancer is unclear.

Finasteride and methadone don't increase advanced liver disease risk in HCV+ male veterans.

Dutasteride is effective for treating prostate enlargement and reducing related surgery risk, but is not approved for preventing prostate cancer.

Finasteride significantly reduces PSA levels in men, and doctors should adjust PSA readings for those taking the drug.

A man developed male breast cancer after four years of finasteride treatment for an enlarged prostate.

Chemotherapy for prostate, bladder, and testicular cancer patients commonly causes hair loss, fatigue, and decreased appetite.

Vertex baldness has higher DHT levels than frontal baldness, but testosterone and PSA levels are similar.

Stiripentol shows promise as a potential treatment for androgen-related diseases but needs more testing.

PSA might help diagnose PCOS and related skin issues, but more research is needed.

PSA can help diagnose high androgen levels in women.

The authors maintain that shorter androgen receptor alleles may lead to milder COVID-19 by positively affecting the immune response, not due to changes in testosterone levels or activity.

Hair loss in young men in Central India is linked to severe heart disease.

Different prostate cancer treatments have similar risks of secondary cancers and related mortality when considering patient age and smoking history.

Male pattern baldness may predict prostate cancer risk.

Patients with metabolic syndrome had lower Gleason scores when diagnosed with prostate cancer.

Many adult women experience unexplained excessive hair shedding, often starting before age 40.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

Opioid use may lower PSA levels, suggesting a possible role in prostate cancer control; PSA testing is useful for detecting prostate cancer; serum triglycerides are not linked to prostate cancer risk; and higher urethral PSA levels may be associated with local hormone activity.

The document does not confirm if radical prostatectomy is the best treatment for locally advanced prostate cancer.